Reducing low density lipoprotein cholesterol (LDL-C) in homozygous familial hypercholesterolemia (HoFH) with a microsomal triglyceride transfer protein (MTP) inhibitor may reduce CV events
Event:
ESC Congress 2016
Topic:
Primary cardiovascular prevention: interventions and outcomes
Session:
What's new in hereditary dyslipidaemia?